• Home
  • What is ALD?
  • Diagnosing ALD
  • Treating ALD
  • Research & Clinical Trials
  • FAQ's
  • News
  • Resources
    • Our Beginning
    • Mission
    • Advisory Board
    • Team
  • Contact Us
  • Donate Now!
Menu

The Stop ALD Foundation

Suite 2000
Houston, TX 77002
+1.713.756.3232
Adrenoleukodystrophy (ALD) therapy development, awareness, & prevention.

Your Custom Text Here

The Stop ALD Foundation

  • Home
  • What is ALD?
  • Diagnosing ALD
  • Treating ALD
  • Research & Clinical Trials
  • FAQ's
  • News
  • Resources
  • About
    • Our Beginning
    • Mission
    • Advisory Board
    • Team
  • Contact Us
  • Donate Now!

MedDay MD1003 clinical trial data

February 5, 2017 Steve Barsh

Per MedDay, the final MD1003 clinical trial data in AMN patients is expected the end of 2017.

← 2017 Million Dollar Bike Ride Pilot Grant Program: Request for Applications$100,000 AMN Research Grant Awarded to Dr. Florian Eichler, Massachusetts General Hospital →

Copyright (c) 2004 - Present by The Stop ALD Foundation. All Rights Reserved.